219 related articles for article (PubMed ID: 25988524)
61. Selective Targeting of RSK Isoforms in Cancer.
Casalvieri KA; Matheson CJ; Backos DS; Reigan P
Trends Cancer; 2017 Apr; 3(4):302-312. PubMed ID: 28718440
[TBL] [Abstract][Full Text] [Related]
62. Recruitment of the extracellular signal-regulated kinase/ribosomal S6 kinase signaling pathway to the NFATc4 transcription activation complex.
Yang TT; Xiong Q; Graef IA; Crabtree GR; Chow CW
Mol Cell Biol; 2005 Feb; 25(3):907-20. PubMed ID: 15657420
[TBL] [Abstract][Full Text] [Related]
63. The Clinical Implications of RSK1-3 in Human Breast Cancer.
Zhao H; Martin TA; Davies EL; Ruge F; Yu H; Zhang Y; Teng XU; Jiang WG
Anticancer Res; 2016 Mar; 36(3):1267-74. PubMed ID: 26977024
[TBL] [Abstract][Full Text] [Related]
64. Regulation of cardiac stress signaling by protein kinase d1.
Harrison BC; Kim MS; van Rooij E; Plato CF; Papst PJ; Vega RB; McAnally JA; Richardson JA; Bassel-Duby R; Olson EN; McKinsey TA
Mol Cell Biol; 2006 May; 26(10):3875-88. PubMed ID: 16648482
[TBL] [Abstract][Full Text] [Related]
65. The p90 RSK family members: common functions and isoform specificity.
Lara R; Seckl MJ; Pardo OE
Cancer Res; 2013 Sep; 73(17):5301-8. PubMed ID: 23970478
[TBL] [Abstract][Full Text] [Related]
66. Central role for BRAF in cardiac hypertrophy: rethinking the pathological-physiological divide.
Altara R; Booz GW
Clin Sci (Lond); 2023 Jan; 137(2):143-148. PubMed ID: 36651286
[TBL] [Abstract][Full Text] [Related]
67. The tumor suppressor DAP kinase is a target of RSK-mediated survival signaling.
Anjum R; Roux PP; Ballif BA; Gygi SP; Blenis J
Curr Biol; 2005 Oct; 15(19):1762-7. PubMed ID: 16213824
[TBL] [Abstract][Full Text] [Related]
68. Ecto-5'-nucleotidase deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction.
Xu X; Fassett J; Hu X; Zhu G; Lu Z; Li Y; Schnermann J; Bache RJ; Chen Y
Hypertension; 2008 Jun; 51(6):1557-64. PubMed ID: 18391093
[TBL] [Abstract][Full Text] [Related]
69. Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells.
Stratford AL; Fry CJ; Desilets C; Davies AH; Cho YY; Li Y; Dong Z; Berquin IM; Roux PP; Dunn SE
Breast Cancer Res; 2008; 10(6):R99. PubMed ID: 19036157
[TBL] [Abstract][Full Text] [Related]
70. Src and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure-overload: comparison with acute mechanical stretch.
Takeishi Y; Huang Q; Abe J; Glassman M; Che W; Lee JD; Kawakatsu H; Lawrence EG; Hoit BD; Berk BC; Walsh RA
J Mol Cell Cardiol; 2001 Sep; 33(9):1637-48. PubMed ID: 11549343
[TBL] [Abstract][Full Text] [Related]
71. ERK/RSK-mediated phosphorylation of Y-box binding protein-1 aggravates diabetic cardiomyopathy by suppressing its interaction with deubiquitinase OTUB1.
Zhong X; Wang T; Zhang W; Wang M; Xie Y; Dai L; He X; Madhusudhan T; Zeng H; Wang H
J Biol Chem; 2022 Jun; 298(6):101989. PubMed ID: 35490780
[TBL] [Abstract][Full Text] [Related]
72. Jun N-terminal kinase mediates activation of skeletal muscle glycogen synthase by insulin in vivo.
Moxham CM; Tabrizchi A; Davis RJ; Malbon CC
J Biol Chem; 1996 Nov; 271(48):30765-73. PubMed ID: 8940056
[TBL] [Abstract][Full Text] [Related]
73. Activation of p90 ribosomal S6 kinases by ORF45 of Kaposi's sarcoma-associated herpesvirus is critical for optimal production of infectious viruses.
Fu B; Kuang E; Li W; Avey D; Li X; Turpin Z; Valdes A; Brulois K; Myoung J; Zhu F
J Virol; 2015 Jan; 89(1):195-207. PubMed ID: 25320298
[TBL] [Abstract][Full Text] [Related]
74. Effects of bisindolylmaleimide PKC inhibitors on p90RSK activity in vitro and in adult ventricular myocytes.
Roberts NA; Haworth RS; Avkiran M
Br J Pharmacol; 2005 Jun; 145(4):477-89. PubMed ID: 15821757
[TBL] [Abstract][Full Text] [Related]
75. Sustained intracellular acidosis activates the myocardial Na(+)/H(+) exchanger independent of amino acid Ser(703) and p90(rsk).
Karki P; Coccaro E; Fliegel L
Biochim Biophys Acta; 2010 Aug; 1798(8):1565-76. PubMed ID: 20471361
[TBL] [Abstract][Full Text] [Related]
76. Two widely used RSK inhibitors, BI-D1870 and SL0101, alter mTORC1 signaling in a RSK-independent manner.
Roffé M; Lupinacci FC; Soares LC; Hajj GN; Martins VR
Cell Signal; 2015 Aug; 27(8):1630-42. PubMed ID: 25889895
[TBL] [Abstract][Full Text] [Related]
77. Cardiomyocyte-specific loss of mitochondrial p32/C1qbp causes cardiomyopathy and activates stress responses.
Saito T; Uchiumi T; Yagi M; Amamoto R; Setoyama D; Matsushima Y; Kang D
Cardiovasc Res; 2017 Aug; 113(10):1173-1185. PubMed ID: 28498888
[TBL] [Abstract][Full Text] [Related]
78. Insulin activates RSK (p90 ribosomal S6 kinase) to trigger a new negative feedback loop that regulates insulin signaling for glucose metabolism.
Smadja-Lamère N; Shum M; Déléris P; Roux PP; Abe J; Marette A
J Biol Chem; 2013 Oct; 288(43):31165-76. PubMed ID: 24036112
[TBL] [Abstract][Full Text] [Related]
79. A Novel Protein-Protein Interaction between RSK3 and IκBα and a New Binding Inhibitor That Suppresses Breast Cancer Tumorigenesis.
Yoon HS; Choi SH; Park JH; Min JY; Hyon JY; Yang Y; Jung S; Kim JY; Kim ND; Lee JH; Han EH; Chi SG; Chung YH
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34198590
[TBL] [Abstract][Full Text] [Related]
80. Attenuating PI3K/Akt- mTOR pathway reduces dihydrosphingosine 1 phosphate mediated collagen synthesis and hypertrophy in primary cardiac cells.
Magaye RR; Savira F; Hua Y; Xiong X; Huang L; Reid C; Flynn BL; Kaye D; Liew D; Wang BH
Int J Biochem Cell Biol; 2021 May; 134():105952. PubMed ID: 33609744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
